Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anagrelide hydrochloride (BL4162A) serves as a treatment for essential thrombocytosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 34.00 | |
10 mg | In stock | $ 50.00 | |
25 mg | In stock | $ 81.00 | |
50 mg | In stock | $ 161.00 | |
100 mg | In stock | $ 292.00 | |
200 mg | In stock | $ 457.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Anagrelide hydrochloride (BL4162A) serves as a treatment for essential thrombocytosis. |
In vitro | Anagrelide is an oral imidazoquinazoline agent with an anti-cyclic AMP phosphodiesterase activity and inhibits platelet aggregation in both humans and animals. Anagrelide works by inhibiting the maturation of platelets from megakaryocytes. |
Synonyms | BMY 26538-01, Anagrelide HCl, Agrylin, BL4162A |
Molecular Weight | 292.55 |
Formula | C10H7Cl2N3O·HCl |
CAS No. | 58579-51-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.9 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anagrelide hydrochloride 58579-51-4 Metabolism PDE Phosphodiesterase (PDE) Anagrelide inhibit Inhibitor BMY 26538-01 Anagrelide HCl Agrylin Anagrelide Hydrochloride BL4162A inhibitor